Financials
- Market Capitalization 1.54 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-25.35
ratio cours/chiffre d'affaires
26.85
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2156 | GHRS GH Research PLC - Ordinary Shares | 25.93 USD | +2.29% | -1.37% | +22.48% | +83.12% | 1.61 B USD | ||
| 2159 | AVBP ArriVent BioPharma, Inc. - Common Stock | 32.96 USD | -2.02% | -4.38% | +7.29% | +50.30% | 1.54 B USD | ||
| 2170 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.37 USD | -0.19% | -16.49% | -7.73% | +102.64% | 1.54 B USD | ||
| 2185 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.24 USD | -0.83% | +7.72% | +7.37% | +111.72% | 1.49 B USD |